Dragon Pharma GHK-Cu is a premium-quality copper-binding tripeptide manufactured to rigorous laboratory standards for scientific and research purposes. Composed of the naturally occurring amino acid sequence Glycine-Histidine-Lysine (GHK) complexed with a copper ion (Cu²⁺), GHK-Cu is one of the most extensively studied bioactive peptides in regenerative medicine, tissue remodeling, and skin biology.
Originally identified in human plasma by Dr. Loren Pickart, GHK-Cu occurs naturally throughout the body, although its concentration gradually declines with age. Scientific research has demonstrated its involvement in numerous biological processes, including collagen synthesis, elastin production, extracellular matrix remodeling, antioxidant defense, angiogenesis, and cellular repair. These properties have made GHK-Cu a prominent subject of investigation in skin regeneration, wound healing, hair follicle biology, pulmonary research, neurological health, and gene expression studies.
Every batch of Dragon Pharma GHK-Cu is produced under strict quality control procedures to ensure exceptional purity, consistency, and molecular integrity. The peptide is supplied as a lyophilized (freeze-dried) powder without unnecessary fillers, helping preserve stability during storage while providing reliable performance for laboratory research.
| Property | Value |
|---|---|
| Product | Dragon Pharma GHK-Cu |
| Peptide Type | Copper-Binding Tripeptide |
| Peptide Sequence | Gly-His-Lys |
| Molecular Formula | C14H24N6O4 |
| Molecular Weight | 340.38 g/mol |
| CAS Number | 49557-75-7 |
| PubChem CID | 73587 |
| Synonyms | Glycyl-L-Histidyl-L-Lysine, Prezatide, Gly-His-Lys |
| Form | Lyophilized Peptide Powder |
| Purity | Laboratory Tested |
| Research Classification | Research Use Only |
GHK-Cu consists of the naturally occurring tripeptide Glycine-Histidine-Lysine complexed with a copper ion, forming a highly bioactive peptide complex involved in numerous physiological processes. Copper serves as an essential trace element required for enzymatic activity, connective tissue maintenance, antioxidant protection, and normal cellular metabolism.
Research indicates that GHK-Cu functions as a signaling peptide capable of influencing multiple biological pathways associated with tissue remodeling, extracellular matrix maintenance, and cellular communication. Experimental investigations suggest that it supports collagen formation, elastin organization, fibroblast activity, angiogenesis, and antioxidant defenses while helping regulate inflammatory responses during tissue repair.
These characteristics have positioned GHK-Cu among the most extensively researched regenerative peptides in modern peptide science.
Rather than acting through a single biological target, GHK-Cu appears to influence numerous molecular signaling pathways involved in tissue repair, cellular regeneration, and oxidative balance.
Current experimental research has investigated its interaction with:
These interconnected pathways are associated with connective tissue remodeling, antioxidant protection, immune regulation, angiogenesis, cellular migration, and normal wound repair.
GHK-Cu has become one of the most widely investigated peptides in dermatological and regenerative research. Numerous experimental studies have explored its role in improving connective tissue organization, collagen deposition, elastin synthesis, and dermal remodeling.
Researchers continue to investigate GHK-Cu in laboratory models involving skin elasticity, dermal density, photodamage, fine lines, wrinkle formation, hyperpigmentation, and age-related structural changes. Its ability to influence fibroblast activity and extracellular matrix remodeling has made it a significant area of interest within cosmetic science and regenerative medicine
Experimental studies have demonstrated that GHK-Cu promotes several biological processes involved in tissue repair, including angiogenesis, cell migration, collagen synthesis, connective tissue accumulation, and growth factor production.
Research has examined its potential involvement in:
These findings continue to support ongoing research into tissue regeneration and wound biology.
GHK-Cu has attracted considerable interest in experimental hair biology due to its observed effects on cellular signaling involved in follicle maintenance and tissue remodeling.
Current research continues to investigate its potential relationship with:
These experimental findings have contributed to its widespread use in cosmetic and hair-related research formulations.
Recent laboratory investigations have expanded into pulmonary biology, where GHK-Cu has demonstrated promising antioxidant and anti-inflammatory properties in experimental models.
Published studies have explored its role in:
Researchers continue evaluating its influence on Nrf2 activation, NF-κB inhibition, TGF-β1 signaling, epithelial-mesenchymal transition (EMT), collagen deposition, and matrix metalloproteinase regulation.
Growing scientific interest has focused on GHK-Cu's potential influence on nervous system biology and age-related neurological changes.
Experimental studies have investigated laboratory models involving:
Research suggests that GHK-Cu may influence gene expression patterns associated with healthy neuronal function and oxidative balance, making it an important peptide for ongoing neuroscience research.
Recent investigations have examined GHK-Cu nanoparticles as novel biomaterials with antibacterial properties.
Experimental models have demonstrated activity against bacterial species including:
Researchers continue evaluating self-assembled GHK-Cu nanoparticles for their potential role in tissue engineering, wound care materials, infection control, and biomedical applications.
One of the defining characteristics of GHK-Cu research is its ability to influence gene expression across numerous biological pathways.
Experimental investigations have reported modulation of genes associated with:
These findings continue to position GHK-Cu as a unique signaling peptide within regenerative medicine research.
Several laboratory studies have evaluated GHK-Cu in experimental models involving gene expression associated with breast, prostate, and colon cancer cells.
Research has focused on how the peptide influences cellular signaling, tissue remodeling, and pathological gene expression. These investigations remain preclinical and continue to explore potential molecular mechanisms involved in healthy tissue maintenance.
Dragon Pharma GHK-Cu is manufactured as a lyophilized peptide using advanced freeze-drying technology designed to maximize molecular stability and preserve peptide integrity.
Advantages of lyophilization include:
No unnecessary fillers are used during manufacturing.
For optimal stability, store the lyophilized peptide in a cool, dry environment protected from moisture, heat, and direct sunlight.
Following laboratory reconstitution, researchers commonly store peptide solutions under refrigeration according to established laboratory protocols. Proper handling procedures help preserve peptide stability and molecular integrity throughout research applications.
Dragon Pharma follows rigorous manufacturing and quality assurance standards to deliver dependable research compounds.
Each production batch undergoes comprehensive laboratory evaluation, including:
Analytical techniques such as High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS) are recognized industry standards for confirming peptide identity, purity, and molecular integrity.
Researchers choose Dragon Pharma because of its commitment to pharmaceutical-quality manufacturing and reliable research compounds.
Key advantages include:
Dragon Pharma GHK-Cu is supplied exclusively for laboratory research and scientific investigation. This peptide is intended for qualified researchers and must only be used in accordance with applicable research regulations. It is not approved for human consumption, medical treatment, diagnosis, or therapeutic use.
The information presented on this page is based on peer-reviewed scientific publications investigating GHK-Cu (Copper Peptide) in laboratory and preclinical research. These studies have explored the peptide's biological activity in tissue remodeling, skin regeneration, wound healing, antioxidant defense, angiogenesis, pulmonary biology, neuroscience, and gene expression.
Dragon Pharma supplies GHK-Cu exclusively for research purposes. This compound is not intended for human consumption or therapeutic use.
Working amazing
Been on this for two months have notice a big difference with my skin. Just got my third shipment.